Masoom Seyedeh Nina, Sundaram Karthik M, Ghanouni Pejman, Fütterer Jurgen, Oto Aytekin, Ayyagari Raj, Sprenkle Preston, Weinreb Jeffrey, Arora Sandeep
Department of Radiology, Hospital of University of Pennsylvania, Philadelphia, PA 19104, USA.
Department of Radiology, Stanford University Medical Center, Palo Alto, CA 04304, USA.
Cancers (Basel). 2022 Apr 7;14(8):1860. doi: 10.3390/cancers14081860.
Prostate cancer (PCa) is the second most common cause of cancer death in males. Targeting MRI-visible lesions has led to an overall increase in the detection of clinically significant PCa compared to the prior practice of random ultrasound-guided biopsy of the prostate. Additionally, advances in MRI-guided minimally invasive focal treatments are providing new options for patients with PCa. This review summarizes the currently utilized real-time MRI-guided interventions for PCa diagnosis and treatment.
前列腺癌（PCa）是男性癌症死亡的第二大常见原因。与先前随机超声引导下前列腺穿刺活检的做法相比，针对磁共振成像（MRI）可见病变进行活检已使临床显著前列腺癌的检出率总体有所提高。此外，MRI引导下微创聚焦治疗的进展为前列腺癌患者提供了新的选择。本综述总结了目前用于前列腺癌诊断和治疗的实时MRI引导干预措施。
